PERCHERON THERAPEUTICS LIMITED — Capital/Financing Update 2021

Dec 23, 2021

==> picture [174 x 55] intentionally omitted <==

Notice Under Section 708A (5) of the Corporations Act (ASX Code: ANP)

This notice is given under paragraph (5)e of section 708A of the Corporations Act.

**Type **	Shares
Class	Ordinary
ASX Code	ANP
Date of Issue	24 December 2021
Number Issued	119,979
Issue price per security:	$0.24

Antisense Therapeutics Limited gives notice under section 708A(5)e of the Corporations Act 2001 (Cth) (the “Corporations Act”) that:

1. The abovementioned ordinary shares were issued without disclosure to investors under Part 6D.2 of the Corporations Act;

1. As at the date of this notice the Company has compiled wit:

   • i. The provisions of the Chapter 2M Corporations Act as they apply to the Company; and

   • ii. Section 674 Corporations Act ; and

2. As at the date of this notice there is no “excluded information” (as defined in subsection 708A (7) of

the Corporations Act) which is required to be disclosed by the Company.

For and on behalf of the Company, Kind Regards,

==> picture [71 x 53] intentionally omitted <==

Phillip Hains Company Secretary Antisense Therapeutics Limited

Dated: 24 December 2021

==> picture [497 x 39] intentionally omitted <==